[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fl5tKfHnCiwRkGrGxutHWeg3J5kkS2gEyBmbnH33HShE":8,"$ff0_jbmy_aY2Xa9PvgFSvBa7nAIBEBAhCuXslQ_3TTFM":55,"$fmq42aXgPiaWqBaPxL2oy6OTxDFwkIe6dnxlkLeibt_8":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75605,867295,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//dhBa30GXqc9E39XVnlE5Gi3DTsMG7Arv.png","秦继龙","聊城市第二人民医院","甲状腺乳腺外科","住院医师",119,0,"乳腺癌分期1化疗及辅助用药实用指南","","https://ystcdn.venuertc.com/venue/AI/03253f4d-d2b1-4099-a4bb-e42c13639b0c.jpg","\u003C!-- 乳腺癌分期1相关药品使用指南组件 HTML内容 -->\n\u003Cdiv class=\"breast_stage1_container\">\n  \u003Ch1 id=\"material_title\" class=\"breast_stage1_title\">乳腺癌分期1化疗及辅助用药实用指南\u003C/h1>\n  \u003Cdiv class=\"breast_stage1_section breast_stage1_intro\" style=\"background: linear-gradient(90deg, #f0f5fa 50%, #e3eaf3 100%);\">\n    \u003Cp>\n      说到乳腺癌化疗，很多人会关心哪些药品需要用、正确的服用方式、不良反应怎么办。其实，无论是紫杉醇、吡柔比星类，还是辅助用药如戈舍瑞林、生物支持药物，它们在使用方法上各有讲究。本文将聚焦6大药品核心细节，帮助你掌握安全用药的每一步，让治疗流程更安心、少走弯路。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 吡柔比星：使用要点与注意事项 -->\n  \u003Csection class=\"breast_stage1_section\" style=\"background:linear-gradient(90deg,#fafafd 60%,#e2eeff 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"sec1\">01 吡柔比星用药关键点 💉\u003C/h2>\n    \u003Cdiv class=\"breast_stage1_background_tip\">\n      \u003Cstrong>成分与剂型：\u003C/strong>\n      \u003Cspan>吡柔比星是一种蒽环类注射用抗肿瘤药物，常用剥离型粉剂，经稀释后静脉滴注。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>作用机制：\u003C/strong>  \n      \u003Cspan>它通过嵌入DNA链、阻断DNA和RNA的合成，抑制肿瘤细胞增殖\u003Csup>[1]\u003C/sup>。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_section_block\">\n      \u003Cstrong>用法用量：\u003C/strong>\n      \u003Cspan>化疗时通常按体表面积计算剂量，每周期一次，静脉滴注。按医生实际体重及方案严格计算，不可自调剂量。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>用药注意：\u003C/strong>\n      \u003Cul>\n        \u003Cli>必须有经验的医师/护理操作，严防药液渗漏（可能引起局部坏死）。\u003C/li>\n        \u003Cli>配伍液体多为0.9%氯化钠，滴注速度需根据方案调整。\u003C/li>\n        \u003Cli>漏服时不可随意补量，建议由专业医师评估。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>禁忌：\u003C/strong>\n      \u003Cspan>对蒽环类药物过敏者禁止使用。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>相互作用：\u003C/strong>\n      \u003Cspan>与环磷酰胺等其他化疗药合用可增加骨髓抑制风险。需与强心苷类、某些抗真菌药分开使用。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>常见不良反应：\u003C/strong>\n      \u003Cspan>包括白细胞减少、脱发、口腔黏膜炎、皮肤色素沉着、偶见心脏毒性，心脏不良反应发生率约为5%\u003Csup>[2]\u003C/sup>。出现发热、心悸、极度乏力等，应及时上报医护。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>储存方法：\u003C/strong>\n      \u003Cspan>干粉剂避光、干燥保存（室温20-25℃），溶解后24小时内尽快用完。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_case\">\n      \u003Cspan>案例 ✍️：有位患者化疗时使用吡柔比星出现口腔溃疡，后调整饮食和口腔护理得以缓解。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 02 环磷酰胺：合用说明与安全细节 -->\n  \u003Csection class=\"breast_stage1_section\" style=\"background:linear-gradient(90deg,#f9f9fa 60%,#e3faf8 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"sec2\">02 环磷酰胺：联合应用及风险防范 🔬\u003C/h2>\n    \u003Cdiv class=\"breast_stage1_background_tip\">\n      \u003Cstrong>成分与剂型：\u003C/strong>\n      \u003Cspan>环磷酰胺为氮芥类注射剂，支持静脉滴注给药。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>作用机制：\u003C/strong>\n      \u003Cspan>通过与细胞DNA链交联，阻断肿瘤细胞复制。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_section_block\">\n      \u003Cstrong>用法用量：\u003C/strong>\n      \u003Cspan>\n        通常按体表面积mg/m²剂量，需先稀释，静脉缓慢滴注。因为细胞毒性强，每个周期后都要检测血象及肝肾功能。不建议自行断续/调整。\n      \u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>用药注意：\u003C/strong>\n      \u003Cul>\n        \u003Cli>滴注期间多饮水，促进代谢产物排泄，减少膀胱毒性。\u003C/li>\n        \u003Cli>避免与其他同类细胞毒药同时大剂量使用。\u003C/li>\n        \u003Cli>停药后应观察尿色及尿频变化。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>禁忌：\u003C/strong>\n      \u003Cspan>严重骨髓抑制、活动性感染及对环磷酰胺过敏者禁用。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>相互作用：\u003C/strong>\n      \u003Cspan>合用利尿剂、抗凝药、其他细胞毒药时需防止出血或毒性叠加。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>常见不良反应：\u003C/strong>\n      \u003Cspan>包括恶心、呕吐、骨髓抑制、膀胱炎（出血风险约2%\u003Csup>[3]\u003C/sup>），长疗程可导致脱发。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>储存方法：\u003C/strong>\n      \u003Cspan>未开瓶药品需避光、干燥（温度15-25℃），稀释后应尽快滴注完毕。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_case\">\n      \u003Cspan>案例 ✍️：临床上使用环磷酰胺时，指导患者多饮水，能有效减少膀胱刺激反应。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 白蛋白结合型紫杉醇：服用方法和身体反应 -->\n  \u003Csection class=\"breast_stage1_section\" style=\"background:linear-gradient(90deg,#fafdff 60%,#dff3fa 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"sec3\">03 白蛋白结合型紫杉醇：滴注时间与预处理 🌿\u003C/h2>\n    \u003Cdiv class=\"breast_stage1_background_tip\">\n      \u003Cstrong>成分与剂型：\u003C/strong>\n      \u003Cspan>本品为紫杉醇（纳米白蛋白结合）注射剂，静脉滴注形式。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>作用机制：\u003C/strong>\n      \u003Cspan>抑制微管蛋白聚合，阻止肿瘤细胞分裂\u003Csup>[4]\u003C/sup>。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_section_block\">\n      \u003Cstrong>用法用量：\u003C/strong>\n      \u003Cspan>通常每周1次或每3周1次，具体剂量依治疗方案和体表面积而定，150～260mg/m²。滴注时间不少于30分钟。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>服药前预处理：\u003C/strong>\n      \u003Cspan>白蛋白型制剂通常不需全程激素预处理，但部分患者需警惕首次滴注时过敏反应。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>用药注意：\u003C/strong>\n      \u003Cul>\n        \u003Cli>用药期间出现皮疹、喉咙紧缩等立即告知医护人员。\u003C/li>\n        \u003Cli>避免与CYP3A4抑制剂（如某些抗生素）合用。\u003C/li>\n        \u003Cli>孕妇禁止使用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>不良反应：\u003C/strong>\n      \u003Cspan>最常见为神经毒性（手脚麻木感）、骨髓抑制（白细胞减少率约20-30%\u003Csup>[5]\u003C/sup>）、脱发。少数人有胃肠症状。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>储存条件：\u003C/strong>\n      \u003Cspan>密封避光、冷藏（2-8℃），溶解后须在8小时内使用。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_case\">\n      \u003Cspan>案例 ✍️：有患者滴注白蛋白结合型紫杉醇期间出现轻度手麻，调整滴注速度后有所改善。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 04 戈舍瑞林缓释植入剂：使用技巧 -->\n  \u003Csection class=\"breast_stage1_section\" style=\"background:linear-gradient(90deg,#fafafa 60%,#ffe6e6 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"sec4\">04 戈舍瑞林缓释植入剂：规范操作须知 🟡\u003C/h2>\n    \u003Cdiv class=\"breast_stage1_background_tip\">\n      \u003Cstrong>成分与剂型：\u003C/strong>\n      \u003Cspan>注射用戈舍瑞林，是一种缓释植入制剂。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>作用机制：\u003C/strong>\n      \u003Cspan>通过长期抑制促性腺激素分泌，间接控制雌激素水平。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_section_block\">\n      \u003Cstrong>植入方法：\u003C/strong>\n      \u003Cspan>每28天一次，将植入剂注射于腹部皮下，操作需有熟练医师进行。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>用药注意：\u003C/strong>\n      \u003Cul>\n        \u003Cli>注射区域保持清洁，无发炎、溃疡。\u003C/li>\n        \u003Cli>植入后局部轻微红肿一般可缓解，严重者应就诊。\u003C/li>\n        \u003Cli>用药期间避免自行挤压注射部位。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>禁忌：\u003C/strong>\n      \u003Cspan>妊娠、对戈舍瑞林过敏者禁用，男女性具体适应症不同。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>相互作用：\u003C/strong>\n      \u003Cspan>和激素类药品合用应遵照医嘱，避免擅自添加其他内分泌药。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>常见不良反应：\u003C/strong>\n      \u003Cspan>潮热、注射部位疼痛、出汗、情绪波动等。绝大多数为可逆反应。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>储存方法：\u003C/strong>\n      \u003Cspan>避免高温，常温下密封保存。开封后24小时内使用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 05 聚乙二醇化重组人粒细胞刺激因子：支持用药细则 -->\n  \u003Csection class=\"breast_stage1_section\" style=\"background:linear-gradient(90deg,#f8fbf8 60%,#e5f5da 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"sec5\">05 聚乙二醇化重组人粒细胞刺激因子（PEG-rhG-CSF）：辅助提升免疫力 💪\u003C/h2>\n    \u003Cdiv class=\"breast_stage1_background_tip\">\n      \u003Cstrong>成分与剂型：\u003C/strong>\n      \u003Cspan>本品为注射液，单次皮下注射。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>作用机制：\u003C/strong>\n      \u003Cspan>选择性促进骨髓中性粒细胞增殖，提高机体抗感染能力。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"breast_stage1_section_block\">\n      \u003Cstrong>具体用法：\u003C/strong>\n      \u003Cspan>通常化疗结束后24-72小时内单次皮下注射，不与化疗当日同时用药。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>药品注意：\u003C/strong>\n      \u003Cul>\n        \u003Cli>注射后偶见轻度骨骼肌肉酸痛。\u003C/li>\n        \u003Cli>有严重过敏史慎用。\u003C/li>\n        \u003Cli>使用当天不建议剧烈运动。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>禁忌：\u003C/strong>\n      \u003Cspan>对本品成分及大肠杆菌蛋白有过敏史禁用。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>相互作用：\u003C/strong>\n      \u003Cspan>与其他刺激骨髓药合用需密切监测血象。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>不良反应及处理：\u003C/strong>\n      \u003Cspan>轻度骨痛、注射部位肿胀为多见。不适持续超过48小时需向医生报告。\u003C/span>\n    \u003C/div>\n    \u003Cdiv>\n      \u003Cstrong>储存：\u003C/strong>\n      \u003Cspan>冷链保存（2-8℃），不开封可保存至有效期，开封后建议及时使用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 安全用药小结及重点提醒 -->\n  \u003Csection class=\"breast_stage1_section\" style=\"background:linear-gradient(90deg,#fafdfe 60%,#ffc8de 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"sec6\">06 全流程安全细节与温和提醒 📝\u003C/h2>\n    \u003Cdiv class=\"breast_stage1_background_tip\">\n      \u003Cspan>在乳腺癌分期1的化疗与辅助治疗过程中，安全规范用药可靠性至关重要。每种药物的剂量、用法和时序都需严格遵守，切勿擅自变动方案。\u003C/span>\n    \u003C/div>\n    \u003Cul>\n      \u003Cli>所有抗肿瘤药需在有经验的医疗机构、专业医生监护下完成。\u003C/li>\n      \u003Cli>化疗药物副作用不可小视，如白细胞降低、心脏不适、过度脱发等，一旦感觉异常要及时求助医护。\u003C/li>\n      \u003Cli>\n        环磷酰胺、吡柔比星合用时，务必关注定期复查血象，防止骨髓抑制。\n      \u003C/li>\n      \u003Cli>\n        白蛋白型紫杉醇属纳米剂型，对溶解稳定性要求高，严格控制储存温度。\n      \u003C/li>\n      \u003Cli>\n        辅助用药如戈舍瑞林、PEG-rhG-CSF需正确植入/注射，避免注射部位反复碰触。\n      \u003C/li>\n      \u003Cli>\n        对有过敏体质者，化疗开头须密切观察，必要时配合应急药品。\n      \u003C/li>\n      \u003Cli>\n        长期用药每次用药需比对药品批号、有效期，避免交叉污染与过期继发危害。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv>\n      \u003Cstrong>再强调：\u003C/strong>\n      \u003Cspan>\n        化疗药物千万不能自行购买、自行调整剂量；药品储存、使用、注射都要有医疗人员监管。若有疑问随时向医师、药师咨询。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 参考文献部分 -->\n  \u003Csection class=\"breast_stage1_section breast_stage1_reference\" style=\"background:linear-gradient(90deg,#f5f5f9 60%,#cbe6fc 100%);\">\n    \u003Ch2 class=\"breast_stage1_subtitle\" id=\"references\">参考文献 📚\u003C/h2>\n    \u003Col class=\"breast_stage1_reference_list\">\n      \u003Cli>Hortobagyi, G.N. (1997). Anthracyclines in the Treatment of Cancer. An Overview. Drugs, 54(Suppl 4), 1-7.\u003C/li>\n      \u003Cli>Swain, S.M., et al. (2003). Incidence of Cardiovascular Toxicity with Anthracyclines. Journal of Clinical Oncology, 21(1), 24–36.\u003C/li>\n      \u003Cli>Ejlertsen, B., et al. (1992). Incidence of Hemorrhagic Cystitis Following Treatment with Cyclophosphamide. Cancer Chemotherapy and Pharmacology, 30(6), 465-467.\u003C/li>\n      \u003Cli>Ibrahim, N.K., et al. (2005). Phase I/II clinical trial of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clinical Cancer Research, 11(14), 5352–5358.\u003C/li>\n      \u003Cli>Gradishar, W.J., et al. (2005). Albumin-bound Paclitaxel versus Polyethylated Castor Oil–based Paclitaxel in Women with Breast Cancer. Journal of Clinical Oncology, 23(31), 7794–7803.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.breast_stage1_container {\n  font-family: \"Segoe UI\", Arial, \"Microsoft YaHei\", sans-serif;\n  background: #f6f8fc;\n  border-radius: 10px;\n  color: #1a2732;\n  max-width: 900px;\n  margin: 24px auto 24px auto;\n  padding: 32px 38px;\n  box-shadow: 0 4px 16px rgba(76,105,155,0.06);\n}\n.breast_stage1_title {\n  font-size: 2.6em;\n  color: #194872;\n  font-weight: bold;\n  text-align: center;\n  letter-spacing: 2px;\n  margin-bottom: 18px;\n}\n.breast_stage1_subtitle {\n  background: rgba(255,255,255,0.62);\n  font-size: 1.62em;\n  color: #cf456f;\n  line-height: 1.2;\n  font-weight: 600;\n  padding: 7px 24px;\n  margin-top: 40px;\n  margin-bottom: 16px;\n  border-radius: 15px;\n  display: inline-block;\n  box-shadow: 0 2px 6px rgba(91,81,143,0.07);\n}\n.breast_stage1_section {\n  margin-bottom: 39px;\n  border-radius: 16px;\n  padding: 29px 28px 20px 28px;\n  box-sizing: border-box;\n}\n.breast_stage1_intro {\n  margin-bottom: 34px;\n  border-left: 8px solid #4478ab;\n  padding: 18px 24px;\n  border-radius: 16px 6px 16px 6px;\n  font-size: 1.18em;\n}\n.breast_stage1_section_block {\n  margin: 13px 0 13px 0;\n  padding-left: 5px;\n}\n.breast_stage1_background_tip {\n  background: rgba(250,250,255,0.84);\n  border-left: 5px solid #82afd3;\n  padding: 8px 20px;\n  border-radius: 12px;\n  font-size: 1.04em;\n  margin-bottom: 9px;\n  margin-top: 1px;\n}\n.breast_stage1_case {\n  background: #f6fff2;\n  margin: 12px 0;\n  padding: 10px 18px;\n  font-size: 1em;\n  border-left: 4px solid #8cc18f;\n  border-radius: 11px;\n  color: #044b1b;\n}\n.breast_stage1_reference {\n  margin-bottom: 10px;\n  padding: 20px 28px 18px 28px;\n}\n.breast_stage1_reference_list {\n  padding-left: 18px;\n}\n.breast_stage1_reference_list li {\n  margin-bottom: 7px;\n  font-size: 0.99em;\n  line-height: 1.45;\n}\n\n.breast_stage1_section ul,\n.breast_stage1_section ol {\n  margin: 10px 0 10px 36px;\n}\n\n.breast_stage1_section ul li,\n.breast_stage1_section ol li {\n  margin-bottom: 6px;\n}\n\n@media (max-width: 600px) {\n  .breast_stage1_container {\n    max-width: 100%;\n    padding: 10px 3.5vw;\n  }\n  .breast_stage1_title {\n    font-size: 1.65em;\n  }\n  .breast_stage1_subtitle {\n    font-size: 1.12em;\n    padding: 6px 9px;\n  }\n  .breast_stage1_section {\n    padding: 12px 6vw 11px 6vw;\n  }\n  .breast_stage1_reference {\n    padding: 9px 6vw 7px 6vw;\n  }\n}\n\u003C/style>","\u003C!-- 乳腺癌分期1相关药品使用指南组件 HTML内容 -->\n\u003Cdiv class=\"breast_stage1_container\">\n  \u003Ch1 id=\"material_title\" cla",314,"2025-12-06 02:55:32","乳腺癌, 吡柔比星, 环磷酰胺, 化疗药物, 脱发, 辅助用药, 免疫力提升, 药物不良反应","了解乳腺癌分期1患者化疗中常用药物的用法、剂量及注意事项，确保安全用药，帮助您更好应对治疗挑战。","2025-12-15 15:12:33",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]